Bi-cytopenia possibly induced by anti-PD-1 antibody for primary malignant melanoma of the esophagus

Abstract

The present case shows a rare but serious life-threatening bi-cytopenia possibly associated with nivolumab and suggests the importance of awareness of hematological adverse events during nivolumab therapy.